Organ-i is a biotech diagnostic company, whose novel tests are radically changing the way renal diseases are diagnosed today. These tests drastically improve the ability of clinicians to monitor the health of transplanted kidneys, and provide valuable treatment information for their patients. Organ-i holds the exclusive license to the patented technology from Stanford University and is now beginning commercial operations in Northern California.